In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
Early data from MajesTEC-1 phase 1-2 studies showed high response rates in patients with relapsed or refractory disease.
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
From the Journals
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
Rare Diseases Report 2021
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.